EVERITT, WILLIAM S – Trademark Portfolio
Entity Type: 01
EVERITT, WILLIAM S holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 15 (Musical Instruments) — 24 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 6 Nice Classification classes. Currently, 18 trademarks are registered. Notable registered marks include KLOSE, MIKAWA, SONATA, TANAKA, and CADENCE. The owner is based in Dallas, TX.
8605 Carpenter Freeway
Dallas, TX 75247
Showing of trademarks Trademarks
Trademark Classifications
EVERITT, WILLIAM S's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does EVERITT, WILLIAM S have?
EVERITT, WILLIAM S has 25 U.S. trademarks filed with the USPTO. Of these, 18 registered, 1 abandoned, 6 cancelled.
What trademark classes does EVERITT, WILLIAM S file in?
EVERITT, WILLIAM S files trademarks across 6 Nice Classification classes. The most active classes are Class 15 (Musical Instruments), Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 41 (Education & Entertainment), Class 4 (Lubricants & Fuels). Class 15 covers musical instruments.
What are EVERITT, WILLIAM S's most well-known trademarks?
EVERITT, WILLIAM S's registered trademark portfolio includes well-known marks such as KLOSE, MIKAWA, SONATA, TANAKA, and CADENCE. These are among 18 currently registered trademarks in the portfolio.
What is EVERITT, WILLIAM S's trademark registration success rate?
EVERITT, WILLIAM S has a 72% trademark registration rate, with 18 out of 25 resolved applications resulting in successful registration. Currently, 0 applications are pending review.